Proteomic analysis of a decellularized human vocal fold mucosa scaffold using 2D electrophoresis and high-resolution mass spectrometry

Biomaterials

Volumn 34, Issue 3, 2013, Pages 669-676

  Welham, Nathan V ^a   Chang, Zhen ^a   Smith, Lloyd M ^b   Frey, Brian L ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Biocompatibility; Extracellular matrix; Larynx; Tissue engineering

Indexed keywords

2-D ELECTROPHORESIS; BIOACTIVE MOLECULES; BIOACTIVE PROTEINS; CELL SEEDING; CELLULAR PROTEINS; DECELLULARIZATION; DECELLULARIZED; DOMINANT SET; ENGINEERED TISSUES; EXTRACELLULAR MATRICES; HIGH RESOLUTION; HIGH RESOLUTION MASS SPECTROMETRY; HOST RESPONSE; IN-VIVO; LARYNX; ONTOLOGY-BASED; PROTEIN SPECIES; PROTEOMIC ANALYSIS; PROTEOMICS; SCAFFOLDS FOR TISSUE ENGINEERING; VOCAL FOLDS;

BIOACTIVITY; BIOCOMPATIBILITY; ELECTROPHORESIS; HISTOLOGY; MASS SPECTROMETRY; MOLECULAR BIOLOGY; PROTEINS; SPEECH; TISSUE; TISSUE ENGINEERING;

SCAFFOLDS (BIOLOGY);

CELL PROTEIN; GLYCOPROTEOME; PHOSPHOPROTEOME; PROTEOME; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; EXTRACELLULAR MATRIX; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MASS SPECTROMETRY; MUCOSA; PRIORITY JOURNAL; PROTEOMICS; TISSUE ENGINEERING; TWO DIMENSIONAL ELECTROPHORESIS; VOCAL CORD;

ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; EXTRACELLULAR MATRIX; HUMANS; MASS SPECTROMETRY; PROTEOME; PROTEOMICS; TISSUE SCAFFOLDS; VOCAL CORDS;

EID: 84868509439     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.09.050     Document Type: Article

References (45)

1. Sellaro T.L., Ranade A., Faulk D.M., McCabe G.P., Dorko K., Badylak S.F., et al. Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. Tissue Eng Part A 2010, 16:1075-1082.
2. Cortiella J., Niles J., Cantu A., Brettler A., Pham A., Vargas G., et al. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. Tissue Eng Part A 2010, 16:2565-2580.
3. Badylak S.F. Xenogeneic extracellular matrix as a scaffold for tissue reconstruction. Transpl Immunol 2004, 12:367-377.
4. Macchiarini P., Jungebluth P., Go T., Asnaghi M.A., Rees L.E.N., Cogan T.A., et al. Clinical transplantation of a tissue-engineered airway. Lancet 2008, 372:2023-2030.
5. Ott H.C., Matthiesen T.S., Goh S.-K., Black L.D., Kren S.M., Netoff T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 2008, 14:213-221.
6. Ott H.C., Clippinger B., Conrad C., Schuetz C., Pomerantseva I., Ikonomou L., et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 2010, 16:927-933.
7. Petersen T.H., Calle E.A., Zhao L., Lee E.J., Gui L., Raredon M.B., et al. Tissue-engineered lungs for in vivo implantation. Science 2010, 329:538-541.
8. Uygun B.E., Soto-Gutierrez A., Yagi H., Izamis M.-L., Guzzardi M.A., Shulman C., et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 2010, 16:814-820.
9. Badylak S.F., Gilbert T.W. Immune response to biologic scaffold materials. Semin Immunol 2008, 20:109-116.
10. Zheng M.-H., Chen J., Kirilak Y., Willers C., Xu J., Wood D. Porcine small intestine submucosa (SIS) is not an acellular collagenous matrix and contains porcine DNA: possible implications in human implantation. J Biomed Mater Res B Appl Biomater 2005, 73:61-67.
11. Brown B.N., Barnes C.A., Kasick R.T., Michel R., Gilbert T.W., Beer-Stolz D., et al. Surface characterization of extracellular matrix scaffolds. Biomaterials 2010, 31:428-437.
12. Barnes C.A., Brison J., Michel R., Brown B.N., Castner D.G., Badylak S.F., et al. The surface molecular functionality of decellularized extracellular matrices. Biomaterials 2011, 32:137-143.
13. Galili U. The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol Cell Biol 2005, 83:674-686.
14. Daly K.A., Liu S., Agrawal V., Brown B.N., Johnson S.A., Medberry C.J., et al. Damage associated molecular patterns within xenogeneic biologic scaffolds and their effects on host remodeling. Biomaterials 2012, 33:91-101.
15. Badylak S.F., Valentin J.E., Ravindra A.K., McCabe G.P., Stewart-Akers A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 2008, 14:1835-1842.
16. Brown B.N., Valentin J.E., Stewart-Akers A.M., McCabe G.P., Badylak S.F. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. Biomaterials 2009, 30:1482-1491.
17. Wallis J.M., Borg Z.D., Daly A.B., Deng B., Ballif B.A., Allen G.B., et al. Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization. Tissue Eng Part C Methods 2012, 18:420-432.
18. Daly A.B., Wallis J.M., Borg Z.D., Bonvillain R.W., Deng B., Ballif B.A., et al. Initial binding and recellularization of decellularized mouse lung scaffolds with bone marrow-derived mesenchymal stromal cells. Tissue Eng Part A 2012, 18:1-16.
19. Titze I.R. The physics of small-amplitude oscillation of the vocal folds. J Acoust Soc Am 1988, 83:1536-1552.
20. Gray S.D., Titze I.R., Alipour F., Hammond T.H. Biomechanical and histologic observations of vocal fold fibrous proteins. Ann Otol Rhinol Laryngol 2000, 109:77-85.
21. Xu C.C., Chan R.W., Tirunagari N. A biodegradable, acellular xenogeneic scaffold for regeneration of the vocal fold lamina propria. Tissue Eng 2007, 13:551-566.
22. Wilson R., Bateman J.F. A robust method for proteomic characterization of mouse cartilage using solubility-based sequential fractionation and two-dimensional gel electrophoresis. Matrix Biol 2008, 27:709-712.
23. Wilson R., Belluoccio D., Bateman J.F. Proteomic analysis of cartilage proteins. Methods 2008, 45:22-31.
24. Belluoccio D., Wilson R., Thornton D.J., Wallis T.P., Gorman J.J., Bateman J.F. Proteomic analysis of mouse growth plate cartilage. Proteomics 2006, 6:6549-6553.
25. Welham N.V., Marriott G., Bless D.M. Proteomic profiling of rat thyroarytenoid muscle. J Speech Lang Hear Res 2006, 49:671-685.
26. Welham N.V., Marriott G., Tateya I., Bless D.M. Proteomic changes in rat thyroarytenoid muscle induced by botulinum neurotoxin injection. Proteomics 2008, 8:1933-1944.
27. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74:5383-5392.
28. Nesvizhskii A.I., Keller A., Kolker E., Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75:4646-4658.
29. Maere S., Heymans K., Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 2005, 21:3448-3449.
30. Cline M.S., Smoot M., Cerami E., Kuchinsky A., Landys N., Workman C., et al. Integration of biological networks and gene expression data using Cytoscape. Nat Protoc 2007, 2:2366-2382.
31. Griffiths L.G., Choe L.H., Reardon K.F., Dow S.W., Orton E.C. Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials 2008, 29:3514-3520.
32. Lehrer R.I., Lichtenstein A.K., Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993, 11:105-128.
33. Sjöberg A.P., Trouw L.A., Blom A.M. Complement activation and inhibition: a delicate balance. Trends Immunol 2009, 30:83-90.
34. Terrier B., Degand N., Guilpain P., Servettaz A., Guillevin L., Mouthon L. Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun Rev 2007, 6:176-182.
35. Beretta B., Conti A., Fiocchi A., Gaiaschi A., Galli C.L., Giuffrida M.G., et al. Antigenic determinants of bovine serum albumin. Int Arch Allergy Immunol 2001, 126:188-195.
36. Iaccarino L., Ghirardello A., Canova M., Zen M., Bettio S., Nalotto L., et al. Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases. Autoimmun Rev 2011, 10:553-558.
37. McKeon F.D., Tuffanelli D.L., Fukuyama K., Kirschner M.W. Autoimmune response directed against conserved determinants of nuclear envelope proteins in a patient with linear scleroderma. Proc Natl Acad Sci U S A 1983, 80:4374-4378.
38. Brito J., Biamonti G., Caporali R., Montecucco C. Autoantibodies to human nuclear lamin B2 protein. Epitope specificity in different autoimmune diseases. J Immunol 1994, 153:2268-2277.
39. Liang Y., Häring M., Roughley P.J., Margolis R.K., Margolis R.U. Glypican and biglycan in the nuclei of neurons and glioma cells: presence of functional nuclear localization signals and dynamic changes in glypican during the cell cycle. J Cell Biol 1997, 139:851-864.
40. Kolset S.O., Prydz K., Pejler G. Intracellular proteoglycans. Biochem J 2004, 379:217-227.
41. Dechat T., Adam S.A., Taimen P., Shimi T., Goldman R.D. Nuclear lamins. Cold Spring Harb Perspect Biol 2010, 2:a000547.
42. Xu C.C., Chan R.W., Weinberger D.G., Efune G., Pawlowski K.S. A bovine acellular scaffold for vocal fold reconstruction in a rat model. J Biomed Mater Res A 2010, 92:18-32.
43. Welham N.V., Yamashita M., Choi S.H., Ling C. Cross-sample validation provides enhanced proteome coverage in rat vocal fold mucosa. PLoS One 2011, 6:e17754.
44. Bordier C. Phase separation of integral membrane proteins in triton X-114 solution. J Biol Chem 1981, 256:1604-1607.
45. Pryde J.G., Phillips J.H. Fractionation of membrane proteins by temperature-induced phase separation in triton X-114. Application to subcellular fractions of the adrenal medulla. Biochem J 1986, 233:525-533.